Skip Ribbon Commands
Skip to main content

Melanoma 

  • CTSU E1609​: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients with High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
For more information, contact Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133​.